Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1297772

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1297772

Global Diagnostic Device Market - 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

The Global Diagnostic Device Market reached US$ 47 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 79.9 billion by 2030. The market is expected to exhibit a CAGR of 6.9% during the forecast period 2023-2030.

Diagnostic devices play a pivotal role in healthcare by enabling early detection, accurate diagnosis, monitoring of diseases, personalized treatment, public health surveillance, and research. Diagnostic devices provide objective and precise information, assisting healthcare professionals in making accurate diagnoses. Diagnostic devices enable the monitoring of diseases and conditions over time, helping healthcare providers assess the effectiveness of treatments and make necessary adjustments.

MarketDynamics

The Rise in chronic disease prevalence is driving the growth of the Diagnostic Device Market.

Chronic diseases are long-term health issues that necessitate continuing management and medical care. They are a major worldwide health concern with far-reaching consequences for individuals, healthcare systems, and society. Chronic diseases are the biggest cause of death and disability around the world.

Noncommunicable diseases (NCDs), which include chronic diseases such as cardiovascular disease, cancer, chronic respiratory diseases, and diabetes, account for nearly 75% of all deaths worldwide, according to the World Health Organisation (WHO). Diabetes, on the other hand, is a chronic metabolic condition characterised by elevated blood sugar levels.

According to the International Diabetes Federation, roughly 463 million adults (20-79 years) had diabetes in 2019, and this figure is expected to climb to 700 million by 2045 if current trends continue. And these factors contribute to market expansion.

Expensive procedures and equipment will hamper the market growth.

The cost of diagnostic devices can vary significantly depending on various factors, including the type of device, its complexity, features, brand, and the region in which it is being purchased. For instance, Ultrasound machines use sound waves to produce images of the body's internal structures. The cost of ultrasound machines can vary significantly depending on their intended use and features. Portable or handheld ultrasound devices may range from $3,000 to $15,000, while high-end, cart-based systems used in medical facilities can cost tens of thousands or more. And thus the cost of procedures will hamper the market growth.

COVID-19 Impact Analysis

The pandemic of COVID-19 has had an extensive effect on diagnostic devices and their use. For example, the pandemic prompted a hitherto unheard-of demand for COVID-19 diagnostic testing. COVID-19 infections have been detected and diagnosed using diagnostic tools such as PCR equipment and rapid antigen assays. The increased demand for testing has increased the manufacturing and use of these devices worldwide.

The COVID-19 pandemic has substantially impacted the diagnostic device landscape, resulting in increased demand, technological advances, supply chain issues, shifts in focus, and regulatory procedure modifications. These changes have short-term ramifications for pandemic management and long-term implications for diagnostic technologies and healthcare delivery.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global diagnostic device market owing to the low prevalence and absence of key market players in this region. However, the effect of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global diagnostic device market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global preeclampsia market positively. AI-enabled diagnostic gadgets can diagnose diseases earlier when treatment outcomes are usually better. These devices can continually monitor and analyze patient data, allowing for real-time detection of irregularities or changes in health indices. Early discovery allows quick action, which may reduce illness development and improve prognosis.

Segment Analysis

The Global Diagnostic Device Market is segmented based on product type, application, end-user and region.

The ultrasound systems segment is estimated to hold most of the diagnostic device market share during the forecast period.

The ultrasound systems ' product type holds about 38.6% of the total diagnostic device market in the forecast period. Ultrasound systems are versatile diagnostic equipment that generates real-time images of the body's internal components using high-frequency sound waves.

They are commonly employed in a variety of medical professions and clinical situations. In radiology, ultrasound is commonly used to evaluate various organs and tissues. It's perfect for imaging soft tissues, including the liver, kidneys, gallbladder, spleen, and thyroid.

And manufacturers are launching new products and highly investing by collaborating with other players to expand their portfolio globally.For instance, on August 26, 2021, Probo Medical, a global leader in medical imaging equipment, parts, repair, and service, has agreed to become an authorised distributor of Mindray North America's ultrasound solutions.

Probo will provide clinicians with immediate and direct access to a wide range of Mindray's unique, category-leading ultrasound imaging instruments and accompanying accessories as a result of this collaboration. And as a result, the market is driven by the leading players' product launches.

Geographical Analysis

During the forecast period, Europe is estimated to hold the second-largest Global Diagnostic Device Market share.

Europe holds the second-largest Global Diagnostic Device Market share, accounting for approximately 28.9% in the forecast period. The greying of Europe is a demographic phenomenon typified by a decline in fertility, a decrease in mortality rate, and a higher life expectancy among European populations. Furthermore, Europe's population is quickly aging, with a growing number of older people.

People's chance of developing chronic diseases such as cardiovascular disease, cancer, diabetes, and respiratory ailments rises as they age. The aging population places a substantial strain on healthcare systems in terms of managing and treating chronic illnesses. For instance, according to World Economic Forum 2022, the European Union and other countries will likely face rapidly aging populations. By 2100, more than 30% of the EU population will be 65 or older. This demographic shift can potentially alter the region's economic prospects significantly.

Competitive Landscape

The major global players in the market include: GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V, Canon Medical Systems Corporation, Carestream Health, Inc, Hologic, Inc, Allengers Medical Systems, SternMed, Neusoft Medical Systems, Medtronic Plc, among others.

Why Purchase the Report?

  • To visualize the Global Diagnostic Device Market segmentation based on product type, application, end user and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous diagnostic device market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Diagnostic Device Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: MD4437

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Chronic Diseases
      • 4.1.1.2. Increased Adoption of Advanced Technologies in Medical Imaging
    • 4.1.2. Restraints
      • 4.1.2.1. Expensive Procedures and Equipment
    • 4.1.3. Opportunity
      • 4.1.3.1. Advances in technology have opened up new possibilities in diagnostic devices
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario before COVID-19
    • 6.1.2. Scenario during COVID-19
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Product type Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 9.1.2. Market Attractiveness Index, By Product type
  • 9.2. X-ray Imaging Systems
    • 9.2.1. X-ray Digital Imaging Systems
    • 9.2.2. X-ray Analog Imaging Systems
    • 9.2.3. Introduction
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Computed Tomography (CT) Scanners
    • 9.3.1. Conventional CT systems
    • 9.3.2. Cone Beam CT Systems (CBCT)
  • 9.4. Ultrasound Systems
    • 9.4.1. 2D Ultrasound
    • 9.4.2. 3D and 4D Ultrasound
    • 9.4.3. Doppler Ultrasound
  • 9.5. Magnetic Resonance Imaging (MRI) Systems
    • 9.5.1. Closed MRI
    • 9.5.2. Open MRI
  • 9.6. Nuclear Imaging Systems
  • 9.7. SPECT Systems
  • 9.8. Hybrid PET Systems
  • 9.9. Mammography Systems

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Orthopedic
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Neurology
  • 10.4. Oncology
  • 10.5. Obstetrics/Gynecology
  • 10.6. Cardiology
  • 10.7. Dental
  • 10.8. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Diagnostic Imaging Centers
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.6.1. The U.S.
      • 12.2.6.2. Canada
      • 12.2.6.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.6.1. Germany
      • 12.3.6.2. The U.K.
      • 12.3.6.3. France
      • 12.3.6.4. Italy
      • 12.3.6.5. Spain
      • 12.3.6.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.6.1. Brazil
      • 12.4.6.2. Argentina
      • 12.4.6.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.6.1. China
      • 12.5.6.2. India
      • 12.5.6.3. Japan
      • 12.5.6.4. Australia
      • 12.5.6.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. GE Healthcare
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Siemens Healthineers
  • 14.3. Koninklijke Philips N.V
  • 14.4. Canon Medical Systems Corporation
  • 14.5. Carestream Health, Inc
  • 14.6. Hologic, Inc
  • 14.7. Allengers Medical Systems
  • 14.8. SternMed
  • 14.9. Neusoft Medical Systems
  • 14.10. Medtronic Plc.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!